Carole Pflumio
Strasbourg, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective study.
Journal: Cancer treatment and research communications
Published: December 23, 2025
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 12, 2025
Impact of Eccentric versus Concentric Cycling Exercise on Neuromuscular Fatigue and Muscle Damage in Breast Cancer Patients.
Journal: Medicine and science in sports and exercise
Published: June 27, 2024
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
Journal: BMC cancer
Published: October 23, 2023
A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 08, 2023
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
Journal: European journal of applied physiology
Published: October 06, 2022
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.
Journal: American journal of physiology. Cell physiology
Published: September 12, 2022
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
Journal: Cancer
Published: August 11, 2022
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
Journal: Cancer treatment and research communications
Published: June 15, 2022
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Journal: Clinical breast cancer
Published: March 21, 2022
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: January 15, 2022
Last Updated: 09/26/2026